Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 08/26 05:35:28 pm
1649.5 GBp   -0.21%
10:04a GLAXOSMITHKLINE : GSK’s continued commitment to innovative res..
08/25 GLAXOSMITHKLINE : GSK) Unveils Take 5 for Meningitis
08/25 INSIDE THE FDA : Frontrunners Merck & Co., Inc. (NYSE:MRK), GlaxoSm..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2012 | 10:46am CEST

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
10:04a GLAXOSMITHKLINE : GSK’s continued commitment to innovative respiratory res..
08/26 GLAXOSMITHKLINE PAKISTAN : Financial results of GlaxoSmithKline Pakistan Limited..
08/25 GLAXOSMITHKLINE PLC (NYSE : GSK) Unveils Take 5 for Meningitis
08/25 INSIDE THE FDA EBOLA EDITION : Frontrunners Merck & Co., Inc. (NYSE:MRK), GlaxoS..
08/25 GLAXOSMITHKLINE : COPD Pocket Consultant App a Useful Addition
08/24 GLAXOSMITHKLINE PAKISTAN : Board meeting of GlaxoSmithKline Pakistan Limited to ..
08/22 UK dividends lagging behind UK
08/22 UK dividends lagging behind
08/20 Cipla, godrej recognised in fortune `change the world' list
08/19 GLAXOSMITHKLINE PAKISTAN : Board meeting of GlaxoSmithKline Pakistan Limited to ..
More news
Sector news : Pharmaceuticals - NEC
03:22p Stada shareholder AOC pushes through board reshuffle
12:43a ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
08/26DJALERE : Sues Abbott to Force Merger -- 2nd Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/26 Denali Lets Rip With Biggest Funding Round
08/23 10 HIV+ patients from CytoDyn's mid-stage study reach two years of complete v..
08/16 Biotechnology Dogs Move Big Pharma Off Healthcare Top Slots In August
08/16 CVRx Holds Its Nerve
08/16 Inovio Zika Phase 1 Clinical Trial Design Superior To NIH Zika Phase 1 Clinic..
Advertisement
Financials ( GBP)
Sales 2016 26 815 M
EBIT 2016 7 264 M
Net income 2016 2 682 M
Debt 2016 13 195 M
Yield 2016 4,85%
P/E ratio 2016 35,06
P/E ratio 2017 21,71
EV / Sales 2016 3,49x
EV / Sales 2017 3,66x
Capitalization 80 410 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 17,2  GBP
Spread / Average Target 4,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Moncef Slaoui Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC20.14%105 625
JOHNSON & JOHNSON15.89%325 679
ROCHE HOLDING LTD.-11.47%214 671
PFIZER INC.7.87%211 206
NOVARTIS AG-9.62%210 234
ASTRAZENECA PLC7.33%173 797
More Results